CHOROIDAL NEVUS IMAGING FEATURES IN 3,806 CASES AND RISK FACTORS FOR TRANSFORMATION INTO MELANOMA IN 2,355 CASES: The 2020 Taylor R. Smith and Victor T. Curtin Lecture

To use multimodal imaging for identification of risk factors for choroidal nevus transformation into melanoma. Retrospective chart review of 3806 consecutive choroidal nevi with imaging and 2355 choroidal nevi with additional follow up to identify factors predictive of transformation of choroidal ne...

Full description

Saved in:
Bibliographic Details
Published inRetina (Philadelphia, Pa.) Vol. 39; no. 10; p. 1840
Main Authors Shields, Carol L, Dalvin, Lauren A, Ancona-Lezama, David, Yu, Michael D, Di Nicola, Maura, Williams, Jr, Basil K, Lucio-Alvarez, J Antonio, Ang, Su Mae, Maloney, Sean, Welch, R Joel, Shields, Jerry A
Format Journal Article
LanguageEnglish
Published United States 01.10.2019
Online AccessGet more information
ISSN1539-2864
DOI10.1097/IAE.0000000000002440

Cover

Loading…
Abstract To use multimodal imaging for identification of risk factors for choroidal nevus transformation into melanoma. Retrospective chart review of 3806 consecutive choroidal nevi with imaging and 2355 choroidal nevi with additional follow up to identify factors predictive of transformation of choroidal nevus into melanoma. The median patient age was 62.5 years and Caucasian race in 3167 (95%). The choroidal nevus demonstrated median basal diameter of 4.0 mm and thickness of 1.4 mm. Imaging included optical coherence tomography (OCT) showing subretinal fluid (SRF) in 312 (9%), ultrasonography (US) with acoustic hollowness in 309 (9%), and hyper-autofluorescence (AF) in 100 (3%). Of those 2355 choroidal nevi with follow up, Kaplan-Meier estimates of nevus transformation into melanoma at 1, 5, and 10 years were 1.2%, 5.8%, and 13.9%, respectively. Multivariate analysis, using multimodal imaging for detection of factors predictive of nevus transformation into melanoma, included thickness >2 mm on US (hazard ratio (HR) 3.80, p < 0.0001), SRF on OCT as cap over nevus (HR 3.00, p < 0.0001) or SRF ≤3 mm from nevus margin (HR 3.56, p = 0.0003), symptomatic vision loss ≤20/50 on Snellen visual acuity (VA) (HR 2.28, p = 0.005), orange pigment (lipofuscin) hyperautofluorescence on AF (HR 3.07, p = 0.0004), acoustic hollowness on US (HR 2.10, p = 0.0020), and tumor diameter >5 mm on photography (HR 1.84, p = 0.0275). These factors can be recalled by the mnemonic "To Find Small Ocular Melanoma Doing IMaging" (TFSOM-DIM) representing Thickness >2 mm (US), Fluid subretinal (OCT), Symptoms vision loss (VA), Orange pigment (AF), Melanoma hollow (US), and DIaMeter >5mm (photography). The mean 5-year estimates of nevus growth into melanoma were 1% (HR 0.8) for those with 0 risk factor, 11% (HR 3.09) with 1 factor, 22% (HR 10.6) with 2 factors, 34% (HR 15.1) with 3 factors, 51% (HR 15.2) with 4 factors, 55% (HR 26.4) with 5 risk factors, and not-estimable with all 6 risk factors. In this analysis, multimodal imaging was capable of detecting risk factors for nevus transformation into melanoma, including thickness >2 mm (US), fluid subretinal (OCT), symptoms vision loss (Snellen acuity), orange pigment (AF), melanoma hollowness (US), and diameter >5 mm (photography). Increasing number of risk factors imparts greater risk for nevus transformation into melanoma, including thickness >2 mm (US), fluid subretinal (OCT), symptoms vision loss (Snellen acuity), orange pigment (AF), melanoma hollowness (US), and diameter >5 mm (photography). Increasing number of risk factors imparts greater risk for transformation.
AbstractList To use multimodal imaging for identification of risk factors for choroidal nevus transformation into melanoma. Retrospective chart review of 3806 consecutive choroidal nevi with imaging and 2355 choroidal nevi with additional follow up to identify factors predictive of transformation of choroidal nevus into melanoma. The median patient age was 62.5 years and Caucasian race in 3167 (95%). The choroidal nevus demonstrated median basal diameter of 4.0 mm and thickness of 1.4 mm. Imaging included optical coherence tomography (OCT) showing subretinal fluid (SRF) in 312 (9%), ultrasonography (US) with acoustic hollowness in 309 (9%), and hyper-autofluorescence (AF) in 100 (3%). Of those 2355 choroidal nevi with follow up, Kaplan-Meier estimates of nevus transformation into melanoma at 1, 5, and 10 years were 1.2%, 5.8%, and 13.9%, respectively. Multivariate analysis, using multimodal imaging for detection of factors predictive of nevus transformation into melanoma, included thickness >2 mm on US (hazard ratio (HR) 3.80, p < 0.0001), SRF on OCT as cap over nevus (HR 3.00, p < 0.0001) or SRF ≤3 mm from nevus margin (HR 3.56, p = 0.0003), symptomatic vision loss ≤20/50 on Snellen visual acuity (VA) (HR 2.28, p = 0.005), orange pigment (lipofuscin) hyperautofluorescence on AF (HR 3.07, p = 0.0004), acoustic hollowness on US (HR 2.10, p = 0.0020), and tumor diameter >5 mm on photography (HR 1.84, p = 0.0275). These factors can be recalled by the mnemonic "To Find Small Ocular Melanoma Doing IMaging" (TFSOM-DIM) representing Thickness >2 mm (US), Fluid subretinal (OCT), Symptoms vision loss (VA), Orange pigment (AF), Melanoma hollow (US), and DIaMeter >5mm (photography). The mean 5-year estimates of nevus growth into melanoma were 1% (HR 0.8) for those with 0 risk factor, 11% (HR 3.09) with 1 factor, 22% (HR 10.6) with 2 factors, 34% (HR 15.1) with 3 factors, 51% (HR 15.2) with 4 factors, 55% (HR 26.4) with 5 risk factors, and not-estimable with all 6 risk factors. In this analysis, multimodal imaging was capable of detecting risk factors for nevus transformation into melanoma, including thickness >2 mm (US), fluid subretinal (OCT), symptoms vision loss (Snellen acuity), orange pigment (AF), melanoma hollowness (US), and diameter >5 mm (photography). Increasing number of risk factors imparts greater risk for nevus transformation into melanoma, including thickness >2 mm (US), fluid subretinal (OCT), symptoms vision loss (Snellen acuity), orange pigment (AF), melanoma hollowness (US), and diameter >5 mm (photography). Increasing number of risk factors imparts greater risk for transformation.
Author Ancona-Lezama, David
Williams, Jr, Basil K
Di Nicola, Maura
Dalvin, Lauren A
Maloney, Sean
Ang, Su Mae
Shields, Carol L
Yu, Michael D
Shields, Jerry A
Welch, R Joel
Lucio-Alvarez, J Antonio
Author_xml – sequence: 1
  givenname: Carol L
  surname: Shields
  fullname: Shields, Carol L
  organization: Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania
– sequence: 2
  givenname: Lauren A
  surname: Dalvin
  fullname: Dalvin, Lauren A
– sequence: 3
  givenname: David
  surname: Ancona-Lezama
  fullname: Ancona-Lezama, David
– sequence: 4
  givenname: Michael D
  surname: Yu
  fullname: Yu, Michael D
– sequence: 5
  givenname: Maura
  surname: Di Nicola
  fullname: Di Nicola, Maura
– sequence: 6
  givenname: Basil K
  surname: Williams, Jr
  fullname: Williams, Jr, Basil K
– sequence: 7
  givenname: J Antonio
  surname: Lucio-Alvarez
  fullname: Lucio-Alvarez, J Antonio
– sequence: 8
  givenname: Su Mae
  surname: Ang
  fullname: Ang, Su Mae
– sequence: 9
  givenname: Sean
  surname: Maloney
  fullname: Maloney, Sean
– sequence: 10
  givenname: R Joel
  surname: Welch
  fullname: Welch, R Joel
– sequence: 11
  givenname: Jerry A
  surname: Shields
  fullname: Shields, Jerry A
BackLink https://www.ncbi.nlm.nih.gov/pubmed/30608349$$D View this record in MEDLINE/PubMed
BookMark eNpNkMtugzAQRa2qVfNo_6Cq5gMSarANdncWgQSVhwROthEPo1AlJCJkkS_qb5YqrdS7mZkjzVncCbpvj61G6MXEhomF8xZIz8D_YlGK79DYZETMLW7TEZqcz58Ym4xz9ohGBNuYEyrG6MtdJWkSLGQIsbdZZxBEchnES_A9qdapN4AYyIxjG1yZDaeMF5AG2Qf40lVJmoGfpKBSGWfDEkkVJPHwohKIvFDGSSR_BNaMMHYTvIPaabCwhUHl1_2xg9SA7ND0O8jbCjZN2Q9MGeBeur5pIdRlf-n0E3qo8_1ZP__OKVr7nnJX8zBZBq4M5yXBTj8XVU11LYjAhDkcCzOva85KbVGR05pwpxR2kZuOo3VZVnWd20wUhGLbxNRhhWlN0evNe7oUB11tT11zyLvr9q8x6xsXMmMx
CitedBy_id crossref_primary_10_3390_cancers12071856
crossref_primary_10_1080_08164622_2021_1878862
crossref_primary_10_1097_IAE_0000000000004111
crossref_primary_10_3390_curroncol29020087
crossref_primary_10_7759_cureus_75056
crossref_primary_10_1167_tvst_10_2_24
crossref_primary_10_3390_life13061253
crossref_primary_10_14260_jemds_2021_157
crossref_primary_10_1007_s40123_023_00790_1
crossref_primary_10_1097_IAE_0000000000003578
crossref_primary_10_1016_j_apjo_2023_100031
crossref_primary_10_1186_s40942_025_00645_w
crossref_primary_10_1038_s41433_023_02864_7
crossref_primary_10_3390_cancers13061306
crossref_primary_10_1159_000529862
crossref_primary_10_1167_iovs_64_14_6
crossref_primary_10_4103_pajo_pajo_135_21
crossref_primary_10_3390_cancers16223839
crossref_primary_10_1016_j_clindermatol_2023_10_012
crossref_primary_10_1245_s10434_024_15038_w
crossref_primary_10_1007_s00347_024_02171_w
crossref_primary_10_1080_08164622_2022_2029685
crossref_primary_10_1080_08820538_2024_2381774
crossref_primary_10_3390_cancers14071809
crossref_primary_10_1167_tvst_13_3_25
crossref_primary_10_1038_s41433_022_02143_x
crossref_primary_10_1111_ceo_14328
crossref_primary_10_1097_IAE_0000000000003114
crossref_primary_10_1177_11206721241235976
crossref_primary_10_3389_fonc_2020_617868
crossref_primary_10_1097_IAE_0000000000003826
crossref_primary_10_1016_j_jcjo_2024_04_003
crossref_primary_10_3390_cancers12051311
crossref_primary_10_1038_s41598_024_78692_w
crossref_primary_10_17116_oftalma20211370415
crossref_primary_10_1038_s41433_023_02782_8
crossref_primary_10_1097_CMR_0000000000000823
crossref_primary_10_3390_cancers16081607
crossref_primary_10_4103_sjopt_sjopt_176_23
crossref_primary_10_37039_1982_8551_20240032
crossref_primary_10_3390_jcm11226666
crossref_primary_10_1038_s41433_024_03148_4
crossref_primary_10_1007_s00247_024_05869_w
crossref_primary_10_1016_j_apjo_2024_100060
crossref_primary_10_1109_ACCESS_2023_3247627
crossref_primary_10_1097_IAE_0000000000004254
crossref_primary_10_1007_s00417_023_05981_x
crossref_primary_10_1007_s00347_022_01740_1
crossref_primary_10_1016_j_jcjo_2023_07_005
crossref_primary_10_3390_cancers14143354
crossref_primary_10_3390_cancers14133147
crossref_primary_10_1016_j_radcr_2021_09_064
crossref_primary_10_17116_oftalma202313903149
crossref_primary_10_1097_ICB_0000000000001416
crossref_primary_10_1167_iovs_64_13_35
crossref_primary_10_3390_jcm13144141
crossref_primary_10_1167_iovs_64_13_1
crossref_primary_10_1080_02713683_2024_2314602
crossref_primary_10_21516_2072_0076_2020_13_4_24_32
crossref_primary_10_1001_jamaophthalmol_2024_6064
crossref_primary_10_4103_ijo_IJO_1217_19
crossref_primary_10_1001_jamaophthalmol_2024_6182
crossref_primary_10_1177_2474126421997335
crossref_primary_10_1016_j_preteyeres_2021_100955
crossref_primary_10_1002_jum_15575
crossref_primary_10_1016_j_oret_2023_07_022
crossref_primary_10_1016_j_survophthal_2024_08_002
crossref_primary_10_1097_IAE_0000000000003053
crossref_primary_10_1016_j_xops_2024_100584
crossref_primary_10_1038_s41572_020_0158_0
crossref_primary_10_1097_ICB_0000000000001096
crossref_primary_10_3390_cancers16152627
crossref_primary_10_1097_ICU_0000000000000744
crossref_primary_10_3390_cancers16122167
crossref_primary_10_1097_OPX_0000000000001915
crossref_primary_10_1016_j_ajo_2022_12_021
crossref_primary_10_31393_morphology_journal_2023_29_3__01
crossref_primary_10_1111_ceo_13805
crossref_primary_10_1016_j_ophtha_2023_07_025
crossref_primary_10_1016_j_preteyeres_2024_101236
crossref_primary_10_1038_s41433_022_02110_6
crossref_primary_10_17116_oftalma2025141011104
crossref_primary_10_1136_bjophthalmol_2021_320682
crossref_primary_10_1007_s00417_023_06130_0
crossref_primary_10_1038_s41433_022_02194_0
ContentType Journal Article
DBID NPM
DOI 10.1097/IAE.0000000000002440
DatabaseName PubMed
DatabaseTitle PubMed
DatabaseTitleList PubMed
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Medicine
EISSN 1539-2864
ExternalDocumentID 30608349
Genre Journal Article
GroupedDBID ---
.-D
.GJ
.Z2
01R
0R~
123
1J1
2V-
40H
53G
5VS
71W
77Y
7O~
AAAAV
AAAXR
AAGIX
AAHPQ
AAIQE
AAMOA
AAMTA
AAQKA
AAQQT
AARTV
AASCR
AASOK
AAXQO
AAYEP
ABASU
ABBUW
ABDIG
ABJNI
ABOCM
ABVCZ
ABXRP
ABXVJ
ABZAD
ACCJW
ACDDN
ACEWG
ACGFS
ACIJW
ACILI
ACLDA
ACWDW
ACWRI
ACXJB
ACXNZ
ADFPA
ADGGA
ADHPY
ADNKB
AE3
AE6
AEETU
AFDTB
AFFNX
AFMFY
AFUWQ
AGINI
AHOMT
AHPAA
AHQNM
AHVBC
AIJEX
AINUH
AJCLO
AJIOK
AJNWD
AJNYG
AJZMW
AKCTQ
AKULP
ALKUP
ALMA_UNASSIGNED_HOLDINGS
ALMTX
AMJPA
AMKUR
AMNEI
AOHHW
AWKKM
BOYCO
BQLVK
BS7
C45
CS3
DIWNM
DUNZO
E.X
EBS
EEVPB
EJD
ERAAH
EX3
F2K
F2L
F2M
F2N
F5P
FCALG
FL-
FW0
GNXGY
GQDEL
H0~
HLJTE
HZ~
IKREB
IKYAY
IN~
IPNFZ
JK3
JK8
K8S
KD2
KMI
L-C
N9A
NPM
N~7
N~B
N~M
O9-
OCUKA
ODA
OJAPA
OL1
OLG
OLH
OLU
OLV
OLW
OLY
OLZ
OPUJH
ORVUJ
OUVQU
OVD
OVDNE
OVIDH
OVLEI
OXXIT
P-K
R58
RIG
RLZ
S4R
S4S
ST3
TEORI
TSPGW
UCJ
V2I
W3M
WOQ
WOW
X3V
X3W
YFH
ZFV
ZGI
ZZMQN
ID FETCH-LOGICAL-c307t-9df4ef93903578091aff85ce249a4f387c96ba177eeccdffa659b340610475b12
IngestDate Wed Feb 19 02:31:37 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 10
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c307t-9df4ef93903578091aff85ce249a4f387c96ba177eeccdffa659b340610475b12
PMID 30608349
ParticipantIDs pubmed_primary_30608349
PublicationCentury 2000
PublicationDate 2019-Oct
PublicationDateYYYYMMDD 2019-10-01
PublicationDate_xml – month: 10
  year: 2019
  text: 2019-Oct
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Retina (Philadelphia, Pa.)
PublicationTitleAlternate Retina
PublicationYear 2019
SSID ssj0015885
Score 2.5478747
Snippet To use multimodal imaging for identification of risk factors for choroidal nevus transformation into melanoma. Retrospective chart review of 3806 consecutive...
SourceID pubmed
SourceType Index Database
StartPage 1840
Title CHOROIDAL NEVUS IMAGING FEATURES IN 3,806 CASES AND RISK FACTORS FOR TRANSFORMATION INTO MELANOMA IN 2,355 CASES: The 2020 Taylor R. Smith and Victor T. Curtin Lecture
URI https://www.ncbi.nlm.nih.gov/pubmed/30608349
Volume 39
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnZ1Lb9NAEIBXKUhVL4h3eWoO3LY2iV_r5WalCTHkgRyn6q1a27sCqQ2RSDn0D_Hb-BfMeO00rQICcrAiOxpFO5_GM7Mzs4y9iaWqikCUjtKedoJIC0dFceiI2IS-LrVXSep3nkyj0SL4cBqedjo_t6qWLteFW17t7Cv5H63iPdQrdcn-g2Y3QvEGfkf94hU1jNe_0nF_NMtm6XEy5tPByWLO00nynrJPw0FdzUDdwdzHRYy7Ee8naDnrYVJZOv_Ih0k_n2VzjkEgz7NkOscvE3sETzrNZ3xCR2nMJgmJ8FAEOgxWRFum4aEHyG28zzOX1xmaeifi5AvtA_Dc5f1LGlHAx3abYtsNzqjRWpF3SwkdmlS5-myrdj8pdys5QSd1n1ffNpUpfJOqPlbn3-34A-rs1svrnGyyxBBfOWN9pS7UrbJ9OoBsq1mgKXdukh49uSmfw3dWa6il48V2Anprye1YpJbY7pZdpjh25wvDDiJOk4EdZNl80Oe58XNc2tVFDRFGWOi02imrf356a4x3-2iP7WFAQye0Ulqp2e4K4zhs-zqleLvr7xyw_VbErQio9oTy--xeE8JAYnl8wDp6-ZDtT5oijUfsxwZLqLGEBktosYR0Cv4RQgk1UYBQAkEJDZSALMJNKIGghBZKEuAdIZJWwDtAIIGABAskZC7UQAICCRZIyF2wQEID5GO2GA7y_shpzgNxSnwTrR1ZmUAb6csujWhCR1cZE4doTwKpAuPHopRRoXpCaLRLlTEqCmXhk8faDURY9Lwn7M7y61IfMhClXxkCS3RNUMWlNEoIKcJehBGLb6Jn7Kld4rOVHfpy1i7-898-ecEOrlF9ye4atDL6Fbqs6-J1re5fryh7QQ
linkProvider National Library of Medicine
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=CHOROIDAL+NEVUS+IMAGING+FEATURES+IN+3%2C806+CASES+AND+RISK+FACTORS+FOR+TRANSFORMATION+INTO+MELANOMA+IN+2%2C355+CASES%3A+The+2020+Taylor+R.+Smith+and+Victor+T.+Curtin+Lecture&rft.jtitle=Retina+%28Philadelphia%2C+Pa.%29&rft.au=Shields%2C+Carol+L&rft.au=Dalvin%2C+Lauren+A&rft.au=Ancona-Lezama%2C+David&rft.au=Yu%2C+Michael+D&rft.date=2019-10-01&rft.eissn=1539-2864&rft.volume=39&rft.issue=10&rft.spage=1840&rft_id=info:doi/10.1097%2FIAE.0000000000002440&rft_id=info%3Apmid%2F30608349&rft_id=info%3Apmid%2F30608349&rft.externalDocID=30608349